Business Description
Enzon Pharmaceuticals Inc
NAICS : 325414
SIC : 2836
ISIN : US2939041081
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.07 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -0.66 | |||||
Beneish M-Score | -2.11 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 18.6 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.56 | |||||
9-Day RSI | 46.63 | |||||
14-Day RSI | 48.08 | |||||
6-1 Month Momentum % | 131.37 | |||||
12-1 Month Momentum % | -2.48 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 113.75 | |||||
Quick Ratio | 113.75 | |||||
Cash Ratio | 112.75 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -4200 | |||||
Net Margin % | 6111.54 | |||||
FCF Margin % | 5295.83 | |||||
ROE % | 52.69 | |||||
ROA % | 3.38 | |||||
ROIC % | -433.32 | |||||
3-Year ROIIC % | 37.59 | |||||
ROCE % | -2.36 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 70.88 | |||||
PE Ratio without NRI | 70.88 | |||||
Shiller PE Ratio | 1.21 | |||||
PB Ratio | 3.46 | |||||
Price-to-Tangible-Book | 3.7 | |||||
Price-to-Free-Cash-Flow | 7.88 | |||||
Price-to-Operating-Cash-Flow | 7.88 | |||||
EV-to-EBIT | 32.24 | |||||
EV-to-EBITDA | 32.24 | |||||
EV-to-Revenue | -1354.28 | |||||
EV-to-FCF | -25.8 | |||||
Price-to-Projected-FCF | 0.85 | |||||
Price-to-Graham-Number | 3.7 | |||||
Price-to-Net-Current-Asset-Value | 3.7 | |||||
Price-to-Net-Cash | 5.55 | |||||
Earnings Yield (Greenblatt) % | 3.1 | |||||
FCF Yield % | 12.41 | |||||
Forward Rate of Return (Yacktman) % | 197.52 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Enzon Pharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.024 | ||
EPS (TTM) (€) | 0.001 | ||
Beta | -0.22 | ||
Volatility % | 98.07 | ||
14-Day RSI | 48.08 | ||
14-Day ATR (€) | 0.006751 | ||
20-Day SMA (€) | 0.1118 | ||
12-1 Month Momentum % | -2.48 | ||
52-Week Range (€) | 0.0465 - 0.182 | ||
Shares Outstanding (Mil) | 74.21 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Enzon Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Enzon Pharmaceuticals Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Enzon Pharmaceuticals Inc Frequently Asked Questions
What is Enzon Pharmaceuticals Inc(STU:EZ1)'s stock price today?
When is next earnings date of Enzon Pharmaceuticals Inc(STU:EZ1)?
Does Enzon Pharmaceuticals Inc(STU:EZ1) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |